This week is World Glaucoma Week. Did you know this eye condition, which can lead to blindness, affects 80 million people worldwide? And that this number is expected to increase to over 111 million by 2040?
At Novo Nordisk Pharmatech, we are proud to be part of the journey to providing better glaucoma medicines. Our Benzalkonium Chloride products are used as an excipient to preserve ophthalmic solutions, gels, and ointments used to treat glaucoma.
Interested in knowing more? You can read more on our dedicated page here.